GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rua Bioscience Ltd (NZSE:RUA) » Definitions » PB Ratio

Rua Bioscience (NZSE:RUA) PB Ratio : 0.75 (As of Dec. 13, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Rua Bioscience PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-13), Rua Bioscience's share price is NZ$0.027. Rua Bioscience's Book Value per Share for the quarter that ended in Jun. 2024 was NZ$0.04. Hence, Rua Bioscience's PB Ratio of today is 0.75.

The historical rank and industry rank for Rua Bioscience's PB Ratio or its related term are showing as below:

NZSE:RUA' s PB Ratio Range Over the Past 10 Years
Min: 0.23   Med: 0.61   Max: 1.32
Current: 0.69

During the past 4 years, Rua Bioscience's highest PB Ratio was 1.32. The lowest was 0.23. And the median was 0.61.

NZSE:RUA's PB Ratio is ranked better than
89.89% of 940 companies
in the Drug Manufacturers industry
Industry Median: 2.075 vs NZSE:RUA: 0.69

During the past 12 months, Rua Bioscience's average Book Value Per Share Growth Rate was -66.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -42.30% per year.

During the past 4 years, the highest 3-Year average Book Value Per Share Growth Rate of Rua Bioscience was -42.30% per year. The lowest was -42.30% per year. And the median was -42.30% per year.

Back to Basics: PB Ratio


Rua Bioscience PB Ratio Historical Data

The historical data trend for Rua Bioscience's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rua Bioscience PB Ratio Chart

Rua Bioscience Annual Data
Trend Jun21 Jun22 Jun23 Jun24
PB Ratio
1.86 2.04 1.21 1.15

Rua Bioscience Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PB Ratio Get a 7-Day Free Trial 2.04 1.27 1.21 1.99 1.15

Competitive Comparison of Rua Bioscience's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Rua Bioscience's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rua Bioscience's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rua Bioscience's PB Ratio distribution charts can be found below:

* The bar in red indicates where Rua Bioscience's PB Ratio falls into.



Rua Bioscience PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Rua Bioscience's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=0.027/0.036
=0.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Rua Bioscience  (NZSE:RUA) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Rua Bioscience PB Ratio Related Terms

Thank you for viewing the detailed overview of Rua Bioscience's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Rua Bioscience Business Description

Traded in Other Exchanges
N/A
Address
1 Commerce Place, Awapuni, Gisborne, NZL, 4071
Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Australia, Germany and New Zealand.

Rua Bioscience Headlines

No Headlines